Send Inquiry
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
Lenshil 4 Mg Capsules
3150 INR/Box
Product Details:
- Ingredients Other
- Application Other
- Storage Instructions Cold & Dry
- Click to View more
X
Lenshil 4 Mg Capsules Price And Quantity
- 3150 INR/Box
- 1 Box
Lenshil 4 Mg Capsules Product Specifications
- Other
- Other
- Cold & Dry
Lenshil 4 Mg Capsules Trade Information
- Western Europe Central America Australia North America South America Middle East Eastern Europe Asia Africa
- All India
Product Description
Lenvatinib is a medication used to treat several types of cancer, including thyroid cancer and liver cancer. It works by blocking the growth and spread of cancer cells.
The typical recommended dose of Lenvatinib capsules is based on the patient's weight and the type of cancer being treated. For thyroid cancer, the usual starting dose is 24 mg (three 8 mg capsules) taken once daily. For liver cancer, the usual starting dose is 12 mg (two 6 mg capsules) taken once daily.
The medication should be swallowed whole with a glass of water and can be taken with or without food. It is important to follow your doctor's instructions and take Lenvatinib exactly as prescribed. Do not change your dose or stop taking the medication without first consulting with your doctor.
Like all medications, Lenvatinib may cause side effects. Common side effects may include fatigue, nausea, diarrhea, decreased appetite, and high blood pressure. More serious side effects may include liver problems, blood clots, and heart problems. If you experience any concerning symptoms or side effects, be sure to speak with your doctor as soon as possible.
Enter Buying Requirement Details
Other Products in 'Anti Cancer Medicine' category
Contact Us
- B No 586/m, Medical Square Road,Nagpur - 440003, Maharashtra, India
- Phone : --7972041639
OM SAI PHARMA
GST : 27CFGPB6851P1ZY
GST : 27CFGPB6851P1ZY
- Mr. Aatish (Proprietor)
- Mobile : +917972041639
-
omsaipharma777@gmail.com
OM SAI PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
